Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | An insight into the prevalence of various subtypes of MGUS in the iStopMM study

Sigurdur Kristinsson, MD, PhD, University of Iceland, Reykjavík, Iceland, shares some insights into the prevalence of various subtypes of monoclonal gammopathy of undetermined significance (MGUS) in the iStopMM study (NCT03327597), and factors influencing these. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Celgene: Research Funding; Amgen: Research Funding.